Join IndieBio NY Class 3 Demo Day on Jan 27: Reserve your virtual tickets now!

Learn more about investing in Biomage

Our team will get back to you soon to follow up on your inquiry.
Lead Rounds?
Biomage
From single-cell data to biological insights
Founded
2019
Employees*
1-10
Funding to Date*
$1.8M
Website
biomage.net
Adam Kurkiewicz, PhD, CEO
Scientists need excellent software. It’s often treated as an afterthought or something that is only a small part of research grants.
Biomage turns meaningful insights from single-cell RNA sequencing from a 3-6 month project into a 1-2 week process, saving time, money, and labor.

Single cell RNA-seq can be used to look at major genetic pathways across multiple cell types (e.g. different types of neurons or blood cells). Its many uses include searching for off-target effects of the lead candidate drug or identifying heterogeneous subclones within a tumour to create predictive models of response to different chemotherapeutics.

Biomage’s product, Cellscope, allows biologists with no prior bioinformatics training to analyse large, multi-sample single cell RNA-seq datasets, perform data integration and execute differential analysis of specific pathways.